Lifestyle
- Regular moderate exercise
- Adequate sleep
- Stress management
Lymphocytes · T-cells · B-cells
Lymphocyte count measures the number of lymphocytes in the blood, reflecting the state of the adaptive immune system.
Reference ranges can vary slightly based on laboratory standards and patient demographics.
Lymphocytes, abbreviated as LYMPH, are a type of white blood cell crucial for the immune system's adaptive response. They include T-cells, B-cells, and natural killer cells, each playing distinct roles in identifying and neutralizing pathogens. Researchers have found that lymphocytes are pivotal in immune surveillance and response, with T-cells directly attacking infected cells and B-cells producing antibodies. Clinically, lymphocyte counts are significant in diagnosing and monitoring conditions such as infections, autoimmune diseases, and hematological disorders. Elevated lymphocyte levels can indicate viral infections or chronic inflammatory conditions, while low levels may suggest immunodeficiency or bone marrow suppression. In the context of athletic performance and biohacking, maintaining optimal lymphocyte levels is associated with robust immune function, potentially reducing infection risk and improving recovery times. However, researchers observed that lymphocyte counts can be influenced by factors such as stress, recent infections, and medications, necessitating careful interpretation of results. Time-of-day variation and fasting status may also affect lymphocyte counts, with levels typically peaking in the afternoon. Therefore, standardized testing conditions are recommended for accurate assessment.
Klinische Bedeutung
Elevated lymphocyte levels may indicate viral infections, chronic inflammation, or lymphoproliferative disorders. Reduced levels can suggest immunodeficiency, bone marrow suppression, or acute stress.
Progressively rising lymphocyte counts may suggest a persistent viral infection or chronic inflammatory condition. Retest in 4 weeks if outside the optimal range.
Progressively falling lymphocyte counts could indicate bone marrow suppression or increased stress.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider before starting new supplements, especially if underlying health conditions exist.
Lymphocyte counts can vary throughout the day, typically peaking in the afternoon.
Testing Frequency
Annually for healthy adults, more frequently if monitoring a specific condition.
May affect
Current research suggests that the optimal strategies for quantifying tumor-infiltrating lymphocytes (TILs) and understanding the functional profiles of different TIL subpopulations remain debated, with no standardized methods established. Researchers have not yet established definitive reference ranges for TILs across various tumor types, leading to uncertainty in their prognostic value. Additionally, clinical questions regarding the specific roles of TILs in response to immunotherapy and the mechanisms of T cell dysfunction remain unanswered.
1,722
Total Citations
22
Human/RCT
3.9
Avg. Influence
2022
Latest
Researchers investigated the presence of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients. They found that PD-1 expression on circulating lymphocytes could identify T cells targeting unique tumor-specific neoantigens, suggesting a noninvasive approach for personalized cancer therapies.
This review addressed the role of tumor-infiltrating lymphocytes (TILs) in breast cancer immunoediting. Researchers found that TILs serve as reliable prognostic biomarkers, particularly in triple-negative and HER2+ subtypes, highlighting their importance in assessing anti-tumor immune activity.
Researchers discussed the role of T lymphocytes in cancer immunotherapy. They found that T cell-mediated anti-tumor responses are central to novel immunotherapy strategies, including checkpoint blockade and CAR T cell therapy. The study emphasizes the need to understand T cell activation and differentiation for effective cancer treatment.
Researchers explored the role of tumor-infiltrating lymphocytes (TILs) in immunotherapy for solid tumors. The study emphasizes the need for standardized methods to evaluate TILs and their functional profiles. It highlights the potential of TILs as biomarkers for predicting responses to immune checkpoint inhibitors.
This study investigated immune changes in breast cancer patients by analyzing cytokine signaling in peripheral blood lymphocytes. Researchers found that dysregulated cytokine signaling in T cells and monocytes may predict relapse risk in breast cancer patients. The results indicate that immune cell alterations are significant biomarkers for assessing the immune status of these patients.
This study focused on exosomal PD-L1 in cancer, highlighting its role in immune suppression. Researchers found that exosomes can transport PD-L1 to inhibit T cell activity in the tumor microenvironment. The study suggests that exosomal PD-L1 could serve as a potential biomarker for cancer immunotherapy.
This study examined drug-induced lupus, a condition triggered by long-term medication use. Researchers found that autoimmunity may be initiated by oxidative metabolites of drugs, leading to the activation of autoreactive lymphocytes. The findings suggest that abnormalities in T-cell selection in the thymus are involved in this autoimmune response.
Researchers found that tumor-infiltrating lymphocytes (TILs) in early breast cancer are associated with better outcomes and responses to therapy. The study highlights the importance of assessing TILs as prognostic and predictive biomarkers in clinical practice. This review discusses potential applications of TILs in improving treatment strategies.
Researchers identified dysfunctional CD16+ CD8 T cells in smokers using single-cell analyses. They found that smoking is associated with an increase in differentiated T cells and a decrease in naïve T cells, indicating immune aging. This study suggests that smoking may lead to immune dysregulation, impacting overall health.
Research publications about Lymphozyten over time
8totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer